# FDA 483 - Clive Ballard, M.D. - May 20, 2022

Source: https://www.globalkeysolutions.net/records/483/clive-ballard-md/19b64d9e-ff02-4f2b-93ad-31278d12dea1

> FDA 483 for Clive Ballard, M.D. on May 20, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Clive Ballard, M.D.
- Inspection Date: 2022-05-20
- Product Type: drugs
- Office Name: Center for Veterinary Medicine
- Summary: An FDA inspection of Clive Ballard, M.D., a clinical investigator in London, revealed significant issues with the conduct of a clinical study. Observations included the enrollment of ineligible subjects due to failure to follow the investigational plan and a failure to obtain proper informed consent from human subjects prior to study procedures. These findings indicate deficiencies in adherence to study protocols and regulatory requirements for human subject protection.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)

Company: https://www.globalkeysolutions.net/companies/clive-ballard-md/2f739c86-3805-484f-90ff-5ddfbcb3a866

Office: https://www.globalkeysolutions.net/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4